C12N 2506/115
From monocytes, from macrophages
Official title: from monocytes, from macrophages
C12N2506/115 (From monocytes, from macrophages) appears on 84 US grants and 172 published applications in this corpus.
Search patents in C12N- Granted patents
- 84
- Published applications
- 172
- Assignees
- 128
- Inventors
- 370
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 3 |
| 2011 | 0 | 1 |
| 2012 | 1 | 3 |
| 2013 | 3 | 7 |
| 2014 | 1 | 3 |
| 2015 | 1 | 14 |
| 2016 | 5 | 9 |
| 2017 | 4 | 5 |
| 2018 | 7 | 8 |
| 2019 | 2 | 17 |
| 2020 | 11 | 13 |
| 2021 | 8 | 14 |
| 2022 | 5 | 21 |
| 2023 | 7 | 11 |
| 2024 | 10 | 15 |
| 2025 | 12 | 13 |
| 2026 | 6 | 10 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- And efficient method for reprogramming blood to induced pluripotent stem cells14 Jul 2026US 12,680,082 B2Cedars-Sinai Medical Center
- C-met and TMX2 antibodies14 Apr 2026US 12,600,786 B2R.G.C.C. Holdings AG
- Reprogramming cells into homeostatic microglia14 Apr 2026US 12,600,942 B2Massachusetts Institute of Technology
- Method of generating multipotent stem cells14 Apr 2026US 12,600,950 B2Fundació Centre De Regulació GenòMica
- Tolerogenic antigen presenting cells24 Mar 2026US 12,582,706 B2Cell4Cure AB
- Production method for induced pluripotent stem cells27 Aug 2026US 2026/0250638 A1Sekisui Chemical Co., Ltd.
- Cell capable of being differentiated into m2 macrophage in tumor tissue and having property such that m2 macrophage differentiated from said cell express inflammatory cytokine, and composition containing said cell6 Aug 2026US 2026/0226412 A1Kyushu University, National University Corporation
- Isolated targeted delivery system for the treatment of ovarian cancer23 Jul 2026US 2026/0207519 A1
- Method for preparing sample containing tumor cells circulating in blood18 Jun 2026US 2026/0167986 A1Novacellum Inc.
- Dendritic cell generating apparatus and method11 Jun 2026US 2026/0159795 A1Flaskworks, LLC
Most cited
By later US patents
- Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides9US 9,497,943 B2Whitehead Institute for Biomedical Research · 2016
- Dendritic cell compositions and methods5US 8,153,425 B2Argos Therapeutics, Inc. · 2012
- Cancer vaccines and vaccination methods4US 10,137,182 B2ImmunoCellular Therapeutics, Ltd. · 2018
- Method of producing natural killer cells and composition for treating cancer4US 10,590,385 B2NKMAX Co., Ltd. · 2020
- Dendritic cell generating apparatus and method4US 10,647,954 B1Flaskworks, LLC · 2020